Source:http://linkedlifedata.com/resource/pubmed/id/17383891
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2007-4-20
|
pubmed:abstractText |
Subjects with chronic kidney disease (CKD) have an increased risk of developing coronary atherosclerosis. Adipocyte hormones, resistin and adiponectin are implicated in insulin resistance and atherosclerosis. However, few studies in the literature address the role of adipocyte hormones in CKD. The aim of this study was to compare the levels of resistin, adiponectin and other inflammatory markers in subjects with CKD with those of the control subjects.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1043-4666
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-5
|
pubmed:dateRevised |
2007-12-3
|
pubmed:meshHeading | |
pubmed:year |
2007
|
pubmed:articleTitle |
Plasma and urine levels of resistin and adiponectin in chronic kidney disease.
|
pubmed:affiliation |
Overton Brooks VAMC/LSUHSC, Endocrinology Section, 510 East Stoner Ave., 111E, Shreveport, LA 71101, USA. Subhashini.Yaturu@med.va.gov
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|